---
layout: post
title: "CDC Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children-United States, 2023; Request for Comment and Notice of Informational Webinar"
date: 2026-02-05 19:01:37 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-25421
original_published: 2022-11-22 00:00:00 +0000
significance: 8.00
---

# CDC Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children-United States, 2023; Request for Comment and Notice of Informational Webinar

**Published:** February 05, 2026 19:01 UTC
**Source:** Federal Register
**Original Published:** November 22, 2022 00:00 UTC
**Document Number:** 2022-25421

## Summary

The Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services (HHS), announces the opening of a docket to obtain comment on proposed new recommendations for perinatal hepatitis C virus (HCV) infection testing to identify infants who may go on to develop chronic hepatitis C. Recommendations include: HCV testing of all perinatally exposed infants at age 2-6 months with a Nucleic Acid Test (NAT) for detection of HCV ribonucleic acid (RNA); and referral of infants with detectable HCV RNA to a healthcare provider with expertise in pediatric hepatitis C management. CDC also announces an Informational Webinar to explain the public comment process.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/11/22/2022-25421/cdc-recommendations-for-hepatitis-c-testing-among-perinatally-exposed-infants-and-children-united)
- API: https://www.federalregister.gov/api/v1/documents/2022-25421

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
